Health Condition 1: I879- Disorder of vein, unspecified
Conditions
Interventions
None listed
Sponsors
Medi Hero Biotech LLP
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis of haemorrhoids more than 3 months. Participants having symptomatic haemorrhoids Goligher Classification Grade I-II. No need to emergency operation according to physical examination. Sodergren Score less than Capable of and freely willing to provide written informed consent prior to participating in the study.
Exclusion criteria
Exclusion criteria: Inflammatory and infectious disease of the digestive tract (like Inflammatory Bowel Diseases). Acute hemorrhoids or complicated hemorrhoids with bleeding requiring admission, such as strangulated internal hemorrhoids, thrombosed internal or external hemorrhoids. Previous hemorrhoidectomy. Moderate to severe hypertension, cardiovascular diseases, renal failure, cirrhosis, colorectal cancer, anal fissure or fistula. Pregnant woman, lactating woman, and woman of childbearing potential who is planning a pregnancy or is unwilling to use appropriate methods of contraception during the study. Participation in an interventional clinical study or administration of any investigational agents in the previous 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Goligher Classification Grade, Pain, Bleeding conditions, Sodergren Score. Vaizey Score.Timepoint: Day 0, 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Laboratory safety parameters (FBS, CBC, LFT and kidney function tests). Occurrence of adverse events.Timepoint: 4 WEEKS | — |
Countries
India
Contacts
Public ContactMrs Supriti Choudhury
J. B. Roy State Ayurvedic Medical College and Hospital
Outcome results
None listed